Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMCD NVWBO:IMCD +0.82%82 Days Sales Outstanding is 64.04 as of Jun. 2026, which is 18% above its 10-year median of 54.29. GuruFocus rates WBO:IMCD with a GF Score™ of 82/100 and a GF Value™ of €128.75 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 1,589 Chemicals companies, IMCD NV ranks worse than 56.14% on this metric.
IMCD NV's average Accounts Receivable for the
six
months ended in Jun. 2026 was €926 Mil. IMCD NV's Revenue for the
six
months ended in Jun. 2026 was €2,638 Mil.
Hence, IMCD NV's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 64.04.
The historical rank and industry rank for IMCD NV's Days Sales Outstanding or its related term are showing as below:
WBO:IMCD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.6 Med: 54.29 Max: 68.12
Current: 68.12
During the past 13 years, IMCD NV's highest Days Sales Outstanding was 68.12. The lowest was 49.60. And the median was 54.29.
WBO:IMCD's Days Sales Outstanding is ranked worse than 56.14% of 1589
companies
in the Chemicals industry
Industry Median: 63.17
vs WBO:IMCD: 68.12
IMCD NV's Days Sales Outstanding
increased
from Jun. 2025 (61.35) to Jun. 2026 (64.04).
IMCD NV (WBO:IMCD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
IMCD NV Days Sales Outstanding Related Terms
IMCD NV Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for IMCD NV's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:IMCD vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, IMCD NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where IMCD NV's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMCD NV (WBO:IMCD) has a Days Sales Outstanding of 64.04 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IMCD NV and its competitors. This is 18% above median its historical median of 54.29. Over the past decade, IMCD NV's Days Sales Outstanding has ranged from 49.60 to 68.12. According to the industry distribution chart, IMCD NV ranks #892 out of 1589 companies in the Chemicals industry, placing it in the top 56.1%.
Is IMCD NV's Days Sales Outstanding too high?
IMCD NV's current Days Sales Outstanding of 64.04 is 18% above median its 10-year median of 54.29. Over the past 10 years, this metric has ranged from a low of 49.60 to a high of 68.12. The Chemicals industry median Days Sales Outstanding is 63.17. IMCD NV's value of 64.04 is 1.4% above this industry median. Based on the distribution chart, IMCD NV ranks #892 out of 1589 companies in the Chemicals industry, which is below the industry midpoint. Overall, IMCD NV has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #892 out of 1589 companies for Days Sales Outstanding. This places IMCD NV in the lower half of its industry. The industry median Days Sales Outstanding is 63.17. IMCD NV's value of 64.04 is 1.4% above this benchmark. Historically, IMCD NV's own Days Sales Outstanding has ranged from 49.60 to 68.12 over the past decade. While the company's 10-year median is 54.29 vs. the industry median of 63.17, IMCD NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.17, based on 1,589 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMCD NV's current Days Sales Outstanding of 64.04 is 1.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IMCD NV and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMCD NV's current Days Sales Outstanding is 64.04, which is 18% above median its own 10-year median of 54.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (WBO:IMCD) is currently considered Modestly Undervalued. The stock's GF Value™ is €128.75, compared to a current price of €95.58 — trading 25.8% below its estimated fair value. The current Days Sales Outstanding is 64.04, which is 18% above median its 10-year median of 54.29 and 1.4% above the Chemicals industry median of 63.17. IMCD NV's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For IMCD NV (WBO:IMCD), the current Days Sales Outstanding is 64.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (WBO:IMCD) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of €95.58 is trading 25.8% below its estimated GF Value™ of €128.75.
GuruFocus considers IMCD NV to be Modestly Undervalued.
Key valuation signals for WBO:IMCD:
Days Sales Outstanding: 64.04 (18% above median its 10-year median of 54.29)
GF Value™: €128.75 vs. price of €95.58 (25.8% below fair value)
Industry Position: 1.4% above the Chemicals median (#892 of 1589)
No single metric tells the full story. See the WBO:IMCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
82GF Score
Get the complete analysis for WBO:IMCD
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:IMCD has been successfully added to your 
